Clinical Trial Update: Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing GSK's HBV-MPL vaccine candidate to Engerix-B in healthy adolescents to evaluate safety and immunogenicity; study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HBV-MPL vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED